US-based bioprocessing company Repligen Corp has announced a public offering of 2,807,017 shares priced at $42.75 each, to raise $120m.

The company plans to use the funds towards working capital and general corporate requirements, including possible acquisitions, products and technologies.

US-based private equity firm CoBe Capital LLC plans to acquire Hill-Rom Holdings’ Volker business.

The divestiture will enable Hill-Rom to enhance its portfolio and focus on key growth platforms.

"The divestiture will enable Hill-Rom to enhance its portfolio and focus on key growth platforms."

Chembio Diagnostics Inc plans to issue common stock shares to raise $21.2m.

The US-based point-of-care diagnostic tests developer plans to use the stocks for general corporate purposes.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Glooko Inc has secured $35m through a series C financing round led by Georgian Partners.

Glooko, a US-based patient monitoring platform provider for diabetes, plans to use the funds to expand its market presence.